Global /Israel /Technology /Software - Application /MPRS
chevron_leftBack
MediPress Health-Limited Partnership logo

MediPress Health-Limited Partnership

MPRS
TLV: MPRS Delayed
56ILA 0%
0.1900 USD
As of 17 June 2026, MediPress Health-Limited Partnership has a market cap of $2.87M USD, ranking #46336 globally and #611 in Israel. It ranks #6868 in the Technology sector, and #2321 in the Software - Application industry.
Global Rank
46336
Country Rank
611
Sector Rank
6868
Industry Rank
2321
Key Stats
Market Cap
$2.87MUSD
8.33M ILS
Company Profile
Country (HQ)
Sector
Technology
Industry
Software - Application
CEO
Joseph Press open_in_new
Founded
2021
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 3.5% 0.9% -13% -8.9% -10%

News

Loading...

Markets

Exchange Ticker Price
Tel Aviv Stock Exchange
MIC: XTAE
PRIMARY
MPRS
מדיפרס בריאות-שותפות מוגבלת Units
ISIN: IL0011828980
TV:
SA:
YF:
GF:
BA:
MS:
56 ILA
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About MediPress Health-Limited Partnership

MediPress Health-Limited Partnership, is a research and development life science partnership and venture capital firm specializing in seed/startups investments. The firm seeks to invest in medical research and development companies. Its portfolio companies engage in the treatment of cancer with proton radiation therapy; and the development of non-surgical vaginal solutions for women with various pelvic floor disorders. The firm seeks to take board positions in its portfolio companies. MediPress Health-Limited Partnership was incorporated in 2021 and is based in Ramat Gan, Israel.

Similar Companies

Industry: Software - Application (Israel)
Name
Market Cap diff.
PE
$14.78B
515K%
14.5
MBLY
$7.35B
256K%
-
WIX
$4.41B
154K%
86.1
MNDY
$3.38B
118K%
29.8
CLBT
$3.17B
110K%
41.0
ETOR
$2.84B
99K%
15.7
Industry: Software - Application (Global)
Name
Market Cap diff.
PE
GOOG
$4.23T
147M%
32.0
MSFT
$3.15T
110M%
26.6
META
$1.7T
59M%
28.5
$551.7B
4.32T HKD
19M%
17.8
ORCL
$471.18B
16M%
29.4
NFLX
$387.9B
14M%
29.8
chevron_leftBack